BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Total assets (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $32.1B | +13.3% | 3.6% | 4.2% |
| Total assets (Q2 2026) | $32.1B |
|---|---|
| YoY | +13.3% |
| 5-year CAGR | 3.6% |
| 10-year CAGR | 4.2% |
Total assets
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $29.4B | +5.0% |
| 2024 | $28.0B | +4.5% |
| 2023 | $26.8B | +9.3% |
| 2022 | $24.6B | +2.8% |
| 2021 | $23.9B | −3.0% |
| 2020 | $24.6B | −9.6% |
| 2019 | $27.2B | +7.7% |
| 2018 | $25.3B | +6.9% |
| 2017 | $23.7B | +3.4% |
| 2016 | $22.9B | +17.3% |
| 2015 | $19.5B | +36.3% |
| 2014 | $14.3B | +20.7% |
| 2013 | $11.9B | +17.1% |
| 2012 | $10.1B | +11.9% |
| 2011 | $9.0B | +11.8% |
| 2010 | $8.1B | −5.4% |
| 2009 | $8.6B | +0.9% |
| 2008 | $8.5B | — |